Literature DB >> 19494015

Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat.

William A McEwan1, Torsten Schaller, Laura M Ylinen, Margaret J Hosie, Greg J Towers, Brian J Willett.   

Abstract

TRIM5alpha mediates a potent retroviral restriction phenotype in diverse mammalian species. Here, we identify a TRIM5 transcript in cat cells with a truncated B30.2 capsid binding domain and ablated restrictive function which, remarkably, is conserved across the Feliformia. Cat TRIM5 displayed no restriction activity, but ectopic expression conferred a dominant negative effect against human TRIM5alpha. Our findings explain the absence of retroviral restriction in cat cells and suggest that disruption of the TRIM5 locus has arisen independently at least twice in the Carnivora, with implications concerning the evolution of the host and pathogen in this taxon.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494015      PMCID: PMC2715776          DOI: 10.1128/JVI.00670-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Retroviral restriction factor TRIM5alpha is a trimer.

Authors:  Claudia C Mische; Hassan Javanbakht; Byeongwoon Song; Felipe Diaz-Griffero; Matthew Stremlau; Bettina Strack; Zhihai Si; Joseph Sodroski
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain.

Authors:  Sara L Sawyer; Lily I Wu; Michael Emerman; Harmit S Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-02       Impact factor: 11.205

3.  Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.

Authors:  M Torten; M Franchini; J E Barlough; J W George; E Mozes; H Lutz; N C Pedersen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.

Authors:  Matthew Stremlau; Michel Perron; Sohanya Welikala; Joseph Sodroski
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  An expanded clade of rodent Trim5 genes.

Authors:  Semih U Tareen; Sara L Sawyer; Harmit S Malik; Michael Emerman
Journal:  Virology       Date:  2009-01-15       Impact factor: 3.616

6.  Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.

Authors:  Theodora Hatziioannou; David Perez-Caballero; Annie Yang; Simone Cowan; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Authors:  Charles R Langelier; Virginie Sandrin; Debra M Eckert; Devin E Christensen; Viswanathan Chandrasekaran; Steven L Alam; Christopher Aiken; John C Olsen; Alak Kanti Kar; Joseph G Sodroski; Wesley I Sundquist
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins.

Authors:  Torsten Schaller; Stéphane Hué; Greg J Towers
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

9.  Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.

Authors:  Torsten Schaller; Laura M J Ylinen; Benjamin L J Webb; Shalene Singh; Greg J Towers
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

10.  All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.

Authors:  Sadayuki Ohkura; Melvyn W Yap; Tom Sheldon; Jonathan P Stoye
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

View more
  34 in total

1.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.

Authors:  Semih U Tareen; Michael Emerman
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

2.  Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.

Authors:  Isabelle Dietrich; Elizabeth L McMonagle; Sarah J Petit; Swetha Vijayakrishnan; Nicola Logan; Chi N Chan; Greg J Towers; Margaret J Hosie; Brian J Willett
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 3.  Retroviral restriction and dependency factors in primates and carnivores.

Authors:  Hind J Fadel; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

4.  Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids.

Authors:  Jörg Zielonka; Daniela Marino; Henning Hofmann; Naoya Yuhki; Martin Löchelt; Carsten Münk
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

5.  Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.

Authors:  James H Morrison; Rebekah B Guevara; Adriana C Marcano; Dyana T Saenz; Hind J Fadel; Daniel K Rogstad; Eric M Poeschla
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

6.  Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.

Authors:  Augustin Penda Twizerimana; Rachel Scheck; Daniel Becker; Zeli Zhang; Marianne Wammers; Leandro Avelar; Marc Pflieger; Dieter Häussinger; Thomas Kurz; Holger Gohlke; Carsten Münk
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

Review 7.  Primate and feline lentiviruses in current intrinsic immunity research: the cat is back.

Authors:  Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

8.  The fate of HIV-1 capsid: a biochemical assay for HIV-1 uncoating.

Authors:  Yang Yang; Jeremy Luban; Felipe Diaz-Griffero
Journal:  Methods Mol Biol       Date:  2014

Review 9.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

10.  Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses.

Authors:  Jumpei Ito; Shinya Watanabe; Takahiro Hiratsuka; Kyohei Kuse; Yuka Odahara; Haruyo Ochi; Maki Kawamura; Kazuo Nishigaki
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.